Use this URL to cite or link to this record in EThOS: https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.822885
Title: Chromatin accessibility reveals regulatory pathways in oesophageal adenocarcinoma
Author: Britton, Edward
Awarding Body: University of Manchester
Current Institution: University of Manchester
Date of Award: 2017
Availability of Full Text:
Access from EThOS:
Access from Institution:
Abstract:
Oesophageal adenocarcinoma (OAC) is one of the ten most prevalent forms of cancer, which is showing a rapid increase in incidence and yet exhibits poor survival rates. Compared to many other common cancers, the molecular changes that occur in this disease are relatively poorly understood although genomic sequencing studies have identified several genes encoding chromatin remodelling enzymes that are frequently mutated in OAC. This finding is consistent with the knowledge that one important change that occurs in cancer cells is a reprogramming of the chromatin environment which leads to subsequent changes in their transcriptional profile. Here, we have used ATAC-seq to interrogate the chromatin changes that occur in OAC. We demonstrate that there are substantial changes in the regulatory chromatin environment in the cancer cells and using this data we have uncovered an important role for ETS and AP1 transcription factors in driving the changes in gene expression found in OAC cells. Furthermore we have developed the technique of ATAC-seq to allow human tissue biopsies to be processed to identify chromatin changes that occur in real life cancer samples, identifying HNF4a GATA4, GATA6 and FOXA2 as putative regulatory transcription factors in a subset of OAC.
Supervisor: Sharrocks, Andrew ; Ang, Yeng Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.822885  DOI: Not available
Keywords: transcription factors ; human tissue ATAC-seq ; chromatin architecture ; RNA-seq ; transcription regulation ; AP1 proteins ; ETS proteins ; GATA ; HNF4a ; chromatin accessibility ; ATAC-seq ; oesophageal adenocarcinoma ; oesophageal cancer
Share: